Positive New for Sun Pharma- Promising Phase 2 study results of inhibitor ILUMYA reported Farhat Nasim15 Jun 2019 5:00 PM ISTMumbai: After facing a series of setbacks on the stock market front Dilip Shanghvi led Sun Pharmaceuticals Limited (Sun Pharma) recently saw some...
Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked Medical Dialogues Bureau14 Jun 2019 12:57 PM ISTJaipur: Discovering that an Ayurvedic firm was selling Ayurvedic diabetes medicines and Dietary Supplements that actually contained the allopathic...
Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition Farhat Nasim13 Jun 2019 3:23 PM ISTNew Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has...
End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS Farhat Nasim12 Jun 2019 11:30 AM ISTIndian drug regulator, the Central Drugs Standard Control Organisation (CDSCO), under the health ministry has proposed that manufacture, sale and...
CDSCO apex committee streamlines drug approval process post clinical trial Farhat Nasim11 Jun 2019 5:08 PM ISTNew Delhi: In a move to oversee clinical trials on new chemical entities, the Central Drug Standard Control Organisation’s (CDSCO) apex committee has...
Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo Farhat Nasim10 Jun 2019 3:51 PM ISTThe Central Drugs Laboratory in Kolkata conducted tests on two different lots of the JnJ baby shampoo after the company contested a finding of the...
Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC Medical Dialogues Bureau9 Jun 2019 11:15 AM ISTThe commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices Medical Dialogues Bureau8 Jun 2019 2:35 PM ISTAs per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
Fighting TB battle: FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment Medical Dialogues Bureau7 Jun 2019 2:53 PM ISTIndependent experts of an FDA advisory panel voted in favour of the not-for-profit TB Alliance's treatment for drug-resistant tuberculosis, as a part...
CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details Farhat Nasim6 Jun 2019 12:11 PM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
Healthcare Startup Pristyn Care raises Rs 27 crore funding from Sequoia India Medical Dialogues Bureau5 Jun 2019 2:36 PM ISTNew Delhi: Healthcare delivery startup Pristyn Care Monday said it has raised USD 4 million (about Rs 27.7 crore) in funding from Sequoia...
NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details Farhat Nasim4 Jun 2019 5:44 PM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
